NuCana (NCNA) Interest & Investment Income (2017 - 2025)
NuCana's (NCNA) quarterly Interest & Investment Income came in at $287414.1 in Q3 2025, up 178.16% year-on-year from $103325.1 in Q3 2024, and up 259.08% quarter-over-quarter from $80042.7 in Q2 2025.
NuCana (NCNA) Interest & Investment Income (2017 - 2025) Analysis & Trends
NuCana has disclosed Interest & Investment Income across 9 years of filings, most recently posting $287414.1 for Q3 2025.
- Interest & Investment Income for Q3 2025 came in at $287414.1, up 178.16% year-over-year; the trailing twelve-month figure through Sep 2025 was $287414.1 (up 178.16% YoY), and the FY2025 annual result was $508945.0, up 11.22% from the prior year.
- Interest & Investment Income came in at $287414.1 for Q3 2025 at NuCana, up from $80042.7 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $781544.5 in Q3 2023 to a low of -$581883.9 in Q2 2023.
- The 5-year median for Interest & Investment Income is $33094.1 (2021), against an average of $38009.9.
- Across the five-year window, Interest & Investment Income soared 301.06% in 2022 and sank 712.44% in 2023, its largest moves.
- NuCana's Interest & Investment Income stood at $111665.3 in 2021, then surged by 301.06% to $447848.4 in 2022, then jumped by 74.51% to $781544.5 in 2023, then slumped by 147.05% to -$367701.9 in 2024, then jumped by 178.16% to $287414.1 in 2025.
- The last three Interest & Investment Income figures came in at $287414.1 (Q3 2025), $80042.7 (Q2 2025), and $31487.5 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 287,414.14 |
| Jun 30, 2025 | 80,042.74 |
| Mar 31, 2025 | 31,487.51 |
| Sep 30, 2024 | -367,701.95 |
| Jun 30, 2024 | 266,328.58 |
| Mar 31, 2024 | 159,833.29 |
| Sep 30, 2023 | 781,544.52 |
| Jun 30, 2023 | -581,883.87 |
| Mar 31, 2023 | -348,851.23 |
| Sep 30, 2022 | 447,848.35 |
| Jun 30, 2022 | -205,268.22 |
| Mar 31, 2022 | -42,938.74 |
| Sep 30, 2021 | 111,665.25 |
| Jun 30, 2021 | -82,465.97 |
| Mar 31, 2021 | 33,094.10 |
| Sep 30, 2020 | 301,977.65 |
| Jun 30, 2020 | 258,272.68 |
| Mar 31, 2020 | -184,588.56 |
| Sep 30, 2019 | -1.07 Mn |
| Jun 30, 2019 | -792,368.57 |